oncology pipeline

NEW YORK, New York, April 30, 2026 OS Therapies announced that the European Medicines Agency (EMA) has initiated a...

New York, USA, April 21,2026 In a major development in global oncology drug innovation, Nuvation Bio Inc. has highlighted...

Cambridge, Massachusetts, USA, April 21, 2026 In a major advancement for targeted cancer therapy, Nuvalent, Inc. has announced the...

SAN DIEGO, Calif., April 21, 2026 Cardiff Oncology, Inc. announced it will present updated Phase 2 data for its...

FOSTER CITY, California, United States & MUNICH, Germany, April 7, 2026 Gilead Sciences, Inc. announced a definitive agreement to...

DORTMUND, Germany, March 17, 2026 iDEL Therapeutics announced the successful close of a €9 million seed financing round led...

THOUSAND OAKS, Calif., February 24, 2026 Amgen announced it will present at the 46th Annual TD Cowen Health Care...

ROCKVILLE, MARYLAND, UNITED STATES — February 17, 2026 NovaBridge announced dosing of the first patient in its global, randomized...

MIRAMAR, Fla., Feb. 16, 2026 — Clinical-stage immunotherapy innovator HCW Biologics and recombinant biologics developer WY Biotech have closed...

Agoura Hills, California — February 10, 2026: Oncotelic Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on oncology, immunotherapy, and...